Micron Biomedical is a clinical-stage life science company committed to expanding access to vaccines and therapeutics globally.

With a mission of radically expanding access to treatments and vaccines to improve global health outcomes, the company is developing a proprietary dissolvable, microarray technology that has been shown to be at least as effective as a traditional injection in adults and children as young as nine-months-old.

Micron Biomedical has been recognized as a category leader and is currently building a mass production facility for needle-free pharmaceuticals.

Micron's Capabilities

Micron Biomedical has state-of-the-art facilities for microneedle formulation, design and process development and cGMP manufacturing.

Formulation, process, and product development

Microarray patch and packaging design, prototyping, testing

Analytical methods

Regulatory strategy and filing

cGMP manufacturing of clinical trial materials

Preclinical and clinical study design and implementation support

The Minds Behind Micron

Micron has assembled a team of scientists, engineers, and quality professionals with vast experience in the medical device, biopharmaceutical, and manufacturing fields.

Leadership Team

Headshot of Steven Damon, CEO

Steven Damon


Mr. Damon is an industry veteran who has over 25 years of experience with various business roles in the medical device and pharmaceutical industries. He served as the President and CEO of 4P Therapeutics, a company he founded in 2011 and sold to Nutriband Inc. in 2018. Steve has held Executive positions in Mergers & Acquisitions, Business Development and Commercial Development for several companies including Femasys, Altea Therapeutics, DURECT, Absorbable Polymers International and Kimberly-Clark Health Care.
Headshot of Devin McAllister

Devin McAllister, PhD

EVP, Chief Technology Officer, Co-founder

Dr. McAllister has 25 years of experience developing medical devices and pharmaceutical dosage forms including microneedle-based patch technologies. He received a BS from Rensselaer Polytechnic Institute and a PhD from the Georgia Institute of Technology, both in chemical engineering. Dr. McAllister leads Micron’s R&D activities, overseeing the development of Micron’s microneedle patch technology and serving as the principal investigator on several grants and contracts including from the Gates Foundation and the CDC. Prior to co-founding Micron, Dr. McAllister was the technical head of Valeritas’ microneedle development program and co-inventor of their lead product, V-Go, the first insulin pump marketed to the large Type 2 diabetes market. He has over 30 US patents issued or pending and has served as a consultant for a number of medical device companies. Prior to Valeritas, he was a Senior R&D Engineer, Diabetes Division, at Johnson & Johnson.
Headshot of Idean Marvasty

Idean Marvasty

EVP, Chief Financial Officer

Mr. Marvasty led the raise of our first institutional financing and has spent over 15 years researching diseases of global impact. He has raised over $270 million in institutional financing for companies he co-founded or led finance and strategy for. Notably, he is an inventor of the first blood-based diagnostic test to diagnose heart disease and has over 25 scientific publications. Prior to Micron, Mr. Marvasty co-founded three life sciences companies and consulted with KPMG where he advised publicly traded and venture-backed companies.

Sebastien Henry, MS, MBA

EVP, Head of Technical Operations, Co-founder

Mr. Henry has over 20 years of research, product development, and project management experience in the microneedle and medical device fields including overall product development responsibilities at Porex Surgical, now owned by Stryker, a company that develops, manufactures, and sells craniofacial implants to surgeons in five surgical specialties. He received a BS from the University of Technology of Compiègne (France) and an MS from the Georgia Institute of Technology, both in bioengineering, as well as an MBA from the Georgia Institute of Technology. Mr. Henry has 8 US patents issued or pending and has worked on microneedles projects at Georgia Tech and Micron for over 10 years.

Board of Directors

Headshot of Brian Bernick, MD

Brian Bernick, MD

Chair, Board of Directors

Labeeb Abboud, JD, PhD

Chairman and CEO at Global Health Investment Corporation

Headshot of Mark Prausnitz, Board of Directors

Mark Prausnitz, PhD

Regents' Professor, Regents' Entrepreneur and J. Erskine Love, Jr. Chair, Georgia Institute of Technology, Micron Biomedical Co-founder

Headshot Bas van Buijtenen. Board of Directors

Bas van Buijtenen

Drug delivery industry veteran and CEO of LTS Lohman